CA OMFS Update: Physician Fee Schedule - Q4 2022

CA OMFS Update: Physician Fee Schedule - Q4 2022

California’s Division of Workers’ Compensation (DWC) issued an update to the Physician and Non-Physician Practitioner portion of the Official Medical Fee Schedule (OMFS) for workers’ compensation, effective for all dates of service on or after October 1, 2022.  

The update adds 31 new procedure codes, all reimbursable “By Report.” The update also alters the status of one existing procedure code, without affecting the reimbursement amount.

Read on for details.

31 New HCPCS Codes

The update conforms the OMFS to relevant 2022 fourth quarter changes to the Centers for Medicare and Medicaid Services (CMS) payment system, as required by California Labor Code Section 5307.1. The DWC announced the update in a recent Newsline, and posted the order adopting the update on the DWC website.

Listed below are the new Healthcare Common Procedure Coding System (HCPCS) codes adopted by the DWC (and CMS) beginning October 2022. All 31 of the new procedure codes are billable By Report (BR).

California Code of Regulations Section 9789.12.4 offers guidelines to determine appropriate reimbursement amounts for BR codes; essentially, providers find a comparable procedure in terms of time, skill, and resources required, and charge accordingly. The provider must justify the amount charged with a separate (non-reimbursable) report.

New HCPCS Codes for CA Workers’ Comp Physician Services

HCPCS

Description

Reimbursement

A9602

Fluorodopa f-18 diag per mci

By Report

A9607

Lutetium lu 177 vipivotide

By Report

A9800

Gallium locametz 1 millicuri

By Report

G0310

Immunize counsel 5-15 min

By Report

G0311

Immunize counsel 16-30 mins

By Report

G0312

Immunize couns < 21yr 5-15 m

By Report

G0313

Immunize couns < 21yr 6-30 m

By Report

G0314

Counsel immune <21 16-30 m

By Report

G0315

Counsel immune <21á 5-15 m

By Report

J1302

Inj, sutimlimab-jome, 10 mg

By Report

J1932

Inj, lanreotide, (cipla) 1mg

By Report

J2777

Inj, faricimab-svoa, 0.1mg

By Report

J9274

Inj, tebentafusp-tebn, 1 mcg

By Report

J9298

Inj nivol relatlimab 3mg/1mg

By Report

Q2056

Ciltacabtagene car-pos t

By Report

Q5125

Inj, releuko 1 mcg

By Report

0041A

Adm sarscov2 5mcg/0.5ml 1st

By Report

0042A

Adm sarscov2 5mcg/0.5ml 2nd

By Report

0074A

Adm sarscv2 10mcg trs-sucr b

By Report

0081A

Adm sarscv2 3mcg trs-sucr 1

By Report

0082A

Adm sarscv2 3mcg trs-sucr 2

By Report

0083A

Adm sarscv2 3mcg trs-sucr 3

By Report

0091A

Adm sarscov2 50 mcg/.5 ml1st

By Report

0092A

Adm sarscov2 50 mcg/.5 ml2nd

By Report

0093A

Adm sarscov2 50 mcg/.5 ml3rd

By Report

0111A

Adm sarscov2 25mcg/0.25ml1st

By Report

0112A

Adm sarscov2 25mcg/0.25ml2nd

By Report

0113A

Adm sarscov2 25mcg/0.25ml3rd

By Report

91304

Sarscov2 vac 5mcg/0.5ml im

By Report

91308

Sarscov2 vac 3 mcg trs-sucr

By Report

91311

Sarscov2 vac 25mcg/0.25ml im

By Report

Status Codes Altered

In addition to the above additions, the DWC update alters the Status Codes of one existing procedure code; however, this code remains billable By Report.

HCPCS

Description

Change

G9678

Oncology care model service

Status Code change only. Remains "By Report."

Lastly, providers may note that the 2022 Q4 update does not include a new telehealth procedure code list.


We obsess over the OMFS — so you don’t have to. Try the daisyWizard, a billing tool that includes our OMFS Calculator for instant, accurate reimbursement rates.

TRY DAISYWIZARD FREE

0 Reader Comments
There are no comments for this article. Be the first to comment!
How did you like the article ?

DaisyBill provides content as an insightful service to its readers and clients. It does not offer legal advice and cannot guarantee the accuracy or suitability of its content for a particular purpose.